title: Biomarker bonanza?
authors.affiliation: Duke Translational Medicine Institute, Durham, North Carolina. Electronic address: robert.califf@duke.edu.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.affiliation: Duke Clinical Research Institute, Durham, North Carolina.
authors.forename: Svati H
authors.initials: SH
authors.lastname: Shah
authors.affiliation: Duke Clinical Research Institute, Durham, North Carolina.
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D054058:Acute Coronary Syndrome / Q000097:blood* / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010879:Piperazines / Q000627:therapeutic use*; D000069458:Ranolazine; D012307:Risk Factors
chemical_list: D000083:Acetanilides; D015415:Biomarkers; D004791:Enzyme Inhibitors; D010879:Piperazines; D020097:Natriuretic Peptide, Brain; D000069458:Ranolazine